Postagens

Mostrando postagens de janeiro, 2021

SABCS 2020 POSTERS PACIENTES COM MUTAÇÃO BRCA !

Imagem
 https://sabcs.onlineeventpro.freeman.com/single-file-viewer/25581217 https://sabcs.onlineeventpro.freeman.com/posters/25581681/A-phase-II-study-to-evaluate-the-efficacy-and-safety-of-Pembrolizumab-plus-Carboplatin-in-BRCA-related-metastatic-breast-cancer-PEMBRACA-trial https://sabcs.onlineeventpro.freeman.com/posters/25582066/Associations-with-response-to-PolyADP-ribose-Polymerase-PARP-inhibitors-in-patients-with-BRCA-mutated-metastatic-breast-cancer-Results-of-a-meta-regression-analysis https://sabcs.onlineeventpro.freeman.com/posters/25582134/Parp-inhibitors-for-treatment-of-brca-positive-metastatic-breast-cancer-a-systematic-review-and-meta-analysis https://sabcs.onlineeventpro.freeman.com/posters/25581843/Efficacy-of-combined-CDK46-inhibitor-and-PARP-inhibitor-in-the-treatment-of-BRCA1-mutant-triple-negative-breast-cancer https://sabcs.onlineeventpro.freeman.com/posters/25582158/Real-world-clinical-outcomes-of-patients-with-BRCA-mutated-BRCAm-HER2-negative-metastatic-breast-cancer

SABCS -POSTER´S SOBRE NOVAS DROGAS , AXIELCTOMIA , SIND LI FRAUMENI

Imagem
  https://sabcs.onlineeventpro.freeman.com/posters/25581599/A-prospective-randomized-multicenter-double-blinded-placebo-controlled-phase-III-trial-of-the-HER2neupeptide-GP2--GM-CSF-versus-bacteriostatic-salineWFI-placebo-as-adjuvant-therapy-after-any-trastuzumab-based-therapy-in-HER2-positive-women-with-operable-breast-cancer https://sabcs.onlineeventpro.freeman.com/posters/25581541/Tailored-axillary-surgery-with-or-without-axillary-lymph-node-dissection-followed-by-radiotherapy-in-patients-with-clinically-node-positive-breast-cancer-SAKK-2316--IBCSG-57-18--ABCSG-53--GBG-101---TAXIS-a-multicenter-randomized-phase-III-trial https://sabcs.onlineeventpro.freeman.com/single-file-viewer/25582199

SABCS 2020 ON LINE PRESENTATION INGRID MAYER "TRATAMENTO DE TUMORES LUMINAIS ER+ ", NÃO É SIMPLESMENTE UMA COISA ÚNICA PARA TODOS( ONE NOT FIT´S ALL)

Imagem
https://sabcs.onlineeventpro.freeman.com/live-stream/19758155/ES1-Educational-Session   NOVIDADES NO TRATAMENTO DE PRIMEIRA LINHA E SEGUNDA LINHA , MECANISMOS DE RESISTENCIA E POSSIBILIDADES TERAPEUTICAS DE ASSOCIAÇÕES ANTI-PI3K, INIB. CICLINA KINASE, TUMORES MUTAÇÃO BRCA.